Skip to main content
The OpeN-AM experimental platform, installed at the VULCAN instrument, features a robotic arm that prints layers of molten metal to create complex shapes. Credit: Jill Hemman/ORNL, U.S Dept. of Energy

Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.  

Cody Lloyd stands in front of images of historical nuclear field testing. The green and red dots are the machine learning algorithm recognizing features in the image. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Cody Lloyd became a nuclear engineer because of his interest in the Manhattan Project, the United States’ mission to advance nuclear science to end World War II. As a research associate in nuclear forensics at ORNL, Lloyd now teaches computers to interpret data from imagery of nuclear weapons tests from the 1950s and early 1960s, bringing his childhood fascination into his career

TIP graphic

Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.

Jerry Parks leads the Molecular Biophysics group at ORNL, leveraging his expertise in computational chemistry and bioinformatics to unlock the inner workings of proteins—molecules that govern cellular structure and function and are essential to life. Credit: Genevieve Martin, ORNL/U.S. Dept. of Energy

When reading the novel Jurassic Park as a teenager, Jerry Parks found the passages about gene sequencing and supercomputers fascinating, but never imagined he might someday pursue such futuristic-sounding science.

Researchers Melissa Cregger, left, and Xiaohan Yang examine plants in an ORNL greenhouse where biosensors are installed to accelerate plant transformations. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy.

Nature-based solutions are an effective tool to combat climate change triggered by rising carbon emissions, whether it’s by clearing the skies with bio-based aviation fuels or boosting natural carbon sinks.

Andrew Lupini

Andrew Lupini, a scientist and inventor at ORNL, has been elected Fellow of the Microscopy Society of America.

ORNL scientists mutated amino acids in a receptor protein, shown in green, which diminished interaction with the SARS-CoV-2 virus spike protein, shown in red. Mutating the receptor protein hampered the virus’s ability to infect host cells. Credit: ORNL, U.S. Dept. of Energy

Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.

An AI-generated image representing atoms and artificial neural networks. Credit: Maxim Ziatdinov, ORNL

Researchers at ORNL have developed a machine-learning inspired software package that provides end-to-end image analysis of electron and scanning probe microscopy images.

Each dot represents a Twitterer discussing COVID-19 from April 16 to April 22, 2021. The closer the dots are to the center, the greater the influence. The brighter the color, the stronger the intent. Image credit: ORNL

Using disinformation to create political instability and battlefield confusion dates back millennia. However, today’s disinformation actors use social media to amplify disinformation that users knowingly or, more often, unknowingly perpetuate. Such disinformation spreads quickly, threatening public health and safety. Indeed, the COVID-19 pandemic and recent global elections have given the world a front-row seat to this form of modern warfare.

Oak Ridge National Laboratory led a team of scientists to design a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and future virus outbreaks. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.